- Home
- ZYME vs PFBC Comparison
ZYME vs PFBC Comparison
Compare ZYME & PFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZYME | PFBC |
|---|---|---|
| Founded | 2003 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2017 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ZYME | PFBC |
|---|---|---|
| Price | $26.58 | $94.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | $28.00 | ★ $104.67 |
| AVG Volume (30 Days) | ★ 1.9M | 69.2K |
| Earning Date | 11-06-2025 | 10-20-2025 |
| Dividend Yield | N/A | ★ 3.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 9.87 |
| Revenue | $134,481,000.00 | ★ $271,347,000.00 |
| Revenue This Year | $65.21 | $3.09 |
| Revenue Next Year | $20.39 | $3.60 |
| P/E Ratio | ★ N/A | $9.57 |
| Revenue Growth | ★ 116.21 | 4.21 |
| 52 Week Low | $9.03 | $71.90 |
| 52 Week High | $28.49 | $99.45 |
Technical Indicators
Market Signals| Indicator | ZYME | PFBC |
|---|---|---|
| Relative Strength Index (RSI) | 73.43 | 60.85 |
| Support Level | $21.89 | $88.89 |
| Resistance Level | $28.49 | $96.00 |
| Average True Range (ATR) | 1.53 | 1.88 |
| MACD | 0.65 | 0.40 |
| Stochastic Oscillator | 84.61 | 77.50 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.